BCL6 and diffuse large B-cell lymphoma: BCL6 represses CCND2 and MYC [27–29, 43]; we have recently shown that MYC expression levels significantly impact the prognosis of MYC rearranged DLBCL [44], and our multivariate analysis suggested BCL6 expression correlated with favorable survival (P = 0.048 for OS and P = 0.016 for PFS, Table 1), therefore the adverse prognostic impact of MYC might have been diminished by high BCL6 expression in these cases.